Cargando…
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis
Mesenchymal stem cell-neural progenitors (MSC-NP) are a neural derivative of MSCs that are being investigated in clinical trials as an autologous intrathecal cell therapy to treat patients with secondary progressive (SP) or primary progressive (PP) multiple sclerosis (MS). MSC-NPs promote tissue rep...
Autores principales: | Harris, Violaine K., Wollowitz, Jaina, Greenwald, Jacelyn, Carlson, Alyssa L., Sadiq, Saud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420335/ https://www.ncbi.nlm.nih.gov/pubmed/37566599 http://dx.doi.org/10.1371/journal.pone.0290069 |
Ejemplares similares
-
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018) -
Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study
por: Harris, Violaine K., et al.
Publicado: (2020) -
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
por: Harris, Violaine K., et al.
Publicado: (2014) -
Genetic code expansion to enable site‐specific bioorthogonal labeling of functional G protein‐coupled receptors in live cells
por: Mattheisen, Jordan M., et al.
Publicado: (2023) -
Biomarkers of multiple sclerosis: current findings
por: Harris, Violaine K, et al.
Publicado: (2017)